Tagrisso is already approved as a first- and ... The AI effect in pharma commercial strategy: From data to re... Discover how AI is transforming the pharma commercial strategy.

Tagrisso (osimertinib) is a brand-name oral tablet that’s prescribed for certain adults with non-small cell lung cancer (NSCLC). The cost of the drug with and without insurance can depend on ...

AZ said that this would make Tagrisso the first EGFR inhibitor to ... Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data.

AstraZeneca AZN announced that the FDA has approved its blockbuster drug, Tagrisso (osimertinib) for expanded use in lung cancer. The regulatory body has approved Tagrisso for the treatment of ...

Tagrisso in the treatment of certain type of lung cancer. The study, called MARIPOSA, showed that at three years of treatment ...

TAGRISSO® (osimertinib ... HUTCHMED (Nasdaq/AIM: HCM; HKEX: 13) is an innovative, commercial-stage, biopharmaceutical company. It is committed to the discovery, global development and ...